Prometheus Biosciences, Inc. announced it has appointed Marla Hochfeld, MD, as Senior Vice President of Clinical Development and Clinical Affairs. Hochfeld will be responsible for leading and expanding the Company's pipeline of immune-mediated programs. Most recently, she served as Vice President, Head of Clinical Development for Immunology and Fibrosis at Bristol Myers Squibb.